+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data



Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data



International Journal of Clinical Practice 62(5): 708-716



To examine medical resource use of Swedish patients with type 2 diabetes during 2000-2004 and to estimate annual costs of care. Retrospective population-based cohort study of patients with type 2 diabetes identified in computerised medical records at 26 primary care centres in Uppsala county, Sweden. Annual quantities of medical resources were determined for prevalent cases during 2000-2004 using register data from outpatient primary care, outpatient hospital care, the National Inpatient Register and a national register for treatment of uraemia. Average costs of care of patients with type 2 diabetes were estimated based on year 2004 resource quantities of 8230 prevalent study cases. Annual quantities of medical resource use were stable in outpatient primary care and outpatient hospital care, with patients making an average of two General Practitioner visits and 3.5 outpatient hospital visits each year. Higher rates of hospitalisation [12% in 2000 (n = 6711) compared with 16% in 2004 (n = 8230)] led to an increase in the mean (SD) number of inpatient days from 2.3 (11.8) to 2.7 (11.9) (p = 0.040) between 2000 and 2004. Mean (SD) total costs of care in 2004 were EUR 3602 (EUR 9537). Inpatient care was the major contributor to costs, accounting for 57% of total costs while drug costs accounted for an average 7%. Swedish type 2 diabetic patients in this large sample from Uppsala county required steady annual amounts of outpatient care and increasing amounts of inpatient care during 2000-2004. The associated costs in 2004 were substantial, with inpatient care identified as the most important component.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055524791

Download citation: RISBibTeXText

PMID: 18355236

DOI: 10.1111/j.1742-1241.2008.01716.x


Related references

Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden. Value in Health 17(7): A492, 2014

Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden. Value in Health 17(7): A327, 2014

Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. European Journal of Health Economics 17(9): 1117-1124, 2016

Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden. Value in Health 17(7): A497, 2014

Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden. Value in Health 17(7): A491, 2014

Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden. Value in Health 17(7): A501, 2014

Diabetes prevalence from health insurance data: evaluation of estimates by comparison with a population-based diabetes register. Diabete and Metabolisme 19(1 Pt 2): 89-95, 1993

Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden. International Journal of Clinical Practice 70(3): 222-228, 2016

Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish National Diabetes Register--register-based cohort study in Sweden. Plos one 9(9): E105868, 2014

Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register. Diabetes Care 42(4): 545-552, 2019

Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study. Value in Health 18(7): A753-A754, 2015

Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data. European Journal of Health Economics 17(5): 591-601, 2016

Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 53(10): 2147-2154, 2010

Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age. European Journal of Health Economics 19(3): 435-446, 2018

Validity of a population-based cancer register in Sweden: An assessment of data reproducibility in the South-East Region Prostate Cancer Register. Scandinavian Journal of Urology and Nephrology 37(2): 112-119, 2003